Global Induced Pluripotent Stem Cells Market Professional Survey Report 2016
- QYR590927
- 109 Pages
- June 2016
- Pharmaceuticals
Product types including
Adult Sources
Fetal Sources
Others
The segment applications including
Hematopoietic stem cell transplantation
Tissue repair damage
Autoimmune diseases
As gene therapy vectors.
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Axiogenesis
Cellectics
Cellular Dynamics
Fate Therapeutics
Iperian
Lonza
Reprocell
Stemgent
System Biosciences
Viacyte
Waisman Biomanufacturing
Regeneus Ltd.
Organogenesis Inc.
Ocata Therapeutics Inc.
Medipost Co. Ltd.
Bone Therapeutics SA
BrainStorm Cell Therapeutics Inc.
CellTherapies P/L
With 18 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Induced Pluripotent Stem Cells
1.1 Definition and Specifications of Induced Pluripotent Stem Cells
1.1.1 Definition of Induced Pluripotent Stem Cells
1.1.2 Specifications of Induced Pluripotent Stem Cells
1.2 Classification of Induced Pluripotent Stem Cells
1.2.1 Adult Sources
1.2.2 Fetal Sources
1.2.3 Others
1.3 Applications of Induced Pluripotent Stem Cells
1.3.1 Hematopoietic stem cell transplantation
1.3.2 Tissue repair damage
1.3.3 Autoimmune diseases
1.3.4 As gene therapy vectors.
1.4 Industry Chain Structure of Induced Pluripotent Stem Cells
1.5 Industry Overview and Major Regions Status of Induced Pluripotent Stem Cells
1.5.1 Industry Overview of Induced Pluripotent Stem Cells
1.5.2 Global Major Regions Status of Induced Pluripotent Stem Cells
1.6 Industry Policy Analysis of Induced Pluripotent Stem Cells
1.7 Industry News Analysis of Induced Pluripotent Stem Cells
2 Manufacturing Cost Structure Analysis of Induced Pluripotent Stem Cells
2.1 Raw Material Suppliers and Price Analysis of Induced Pluripotent Stem Cells
2.2 Equipment Suppliers and Price Analysis of Induced Pluripotent Stem Cells
2.3 Labor Cost Analysis of Induced Pluripotent Stem Cells
2.4 Other Costs Analysis of Induced Pluripotent Stem Cells
2.5 Manufacturing Cost Structure Analysis of Induced Pluripotent Stem Cells
2.6 Manufacturing Process Analysis of Induced Pluripotent Stem Cells
3 Technical Data and Manufacturing Plants Analysis of Induced Pluripotent Stem Cells
3.1 Capacity and Commercial Production Date of Global Induced Pluripotent Stem Cells Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Induced Pluripotent Stem Cells Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Induced Pluripotent Stem Cells Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Induced Pluripotent Stem Cells Major Manufacturers in 2015
4 Global Induced Pluripotent Stem Cells Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Induced Pluripotent Stem Cells Capacity and Growth Rate Analysis
4.2.2 2015 Induced Pluripotent Stem Cells Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Induced Pluripotent Stem Cells Sales and Growth Rate Analysis
4.3.2 2015 Induced Pluripotent Stem Cells Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Induced Pluripotent Stem Cells Sales Price
4.4.2 2015 Induced Pluripotent Stem Cells Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Induced Pluripotent Stem Cells Gross Margin
4.5.2 2015 Induced Pluripotent Stem Cells Gross Margin Analysis (Company Segment)
5 Induced Pluripotent Stem Cells Regional Market Analysis
5.1 North America Induced Pluripotent Stem Cells Market Analysis
5.1.1 North America Induced Pluripotent Stem Cells Market Overview
5.1.2 North America 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.1.4 North America 2015 Induced Pluripotent Stem Cells Market Share Analysis
5.2 Europe Induced Pluripotent Stem Cells Market Analysis
5.2.1 Europe Induced Pluripotent Stem Cells Market Overview
5.2.2 Europe 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.2.4 Europe 2015 Induced Pluripotent Stem Cells Market Share Analysis
5.3 Japan Induced Pluripotent Stem Cells Market Analysis
5.3.1 Japan Induced Pluripotent Stem Cells Market Overview
5.3.2 Japan 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.3.4 Japan 2015 Induced Pluripotent Stem Cells Market Share Analysis
5.4 China Induced Pluripotent Stem Cells Market Analysis
5.4.1 China Induced Pluripotent Stem Cells Market Overview
5.4.2 China 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.4.4 China 2015 Induced Pluripotent Stem Cells Market Share Analysis
5.5 Southeast Asia Induced Pluripotent Stem Cells Market Analysis
5.5.1 Southeast Asia Induced Pluripotent Stem Cells Market Overview
5.5.2 Southeast Asia 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.5.4 Southeast Asia 2015 Induced Pluripotent Stem Cells Market Share Analysis
5.6 India Induced Pluripotent Stem Cells Market Analysis
5.6.1 India Induced Pluripotent Stem Cells Market Overview
5.6.2 India 2011-2016E Induced Pluripotent Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Induced Pluripotent Stem Cells Sales Price Analysis
5.6.4 India 2015 Induced Pluripotent Stem Cells Market Share Analysis
6 Global 2011-2016E Induced Pluripotent Stem Cells Segment Market Analysis (by Type)
6.1 Global 2011-2016E Induced Pluripotent Stem Cells Sales by Type
6.2 Different Types Induced Pluripotent Stem Cells Product Interview Price Analysis
6.3 Different Types Induced Pluripotent Stem Cells Product Driving Factors Analysis
6.3.1 Adult Sources Induced Pluripotent Stem Cells Growth Driving Factor Analysis
6.3.2 Fetal Sources Induced Pluripotent Stem Cells Growth Driving Factor Analysis
6.3.3 Others Induced Pluripotent Stem Cells Growth Driving Factor Analysis
7 Global 2011-2016E Induced Pluripotent Stem Cells Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hematopoietic stem cell transplantation Induced Pluripotent Stem Cells Growth Driving Factor Analysis
7.3.2 Tissue repair damage Induced Pluripotent Stem Cells Growth Driving Factor Analysis
7.3.3 Autoimmune diseases Induced Pluripotent Stem Cells Growth Driving Factor Analysis
7.3.4 As gene therapy vectors. Induced Pluripotent Stem Cells Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Induced Pluripotent Stem Cells
8.1 Axiogenesis
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Axiogenesis 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Axiogenesis 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.2 Cellectics
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Cellectics 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Cellectics 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.3 Cellular Dynamics
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Cellular Dynamics 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Cellular Dynamics 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.4 Fate Therapeutics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Fate Therapeutics 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Fate Therapeutics 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.5 Iperian
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Iperian 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Iperian 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.6 Lonza
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Lonza 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Lonza 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.7 Reprocell
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Reprocell 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Reprocell 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.8 Stemgent
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Stemgent 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Stemgent 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.9 System Biosciences
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 System Biosciences 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 System Biosciences 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.10 Viacyte
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Viacyte 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Viacyte 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.11 Waisman Biomanufacturing
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Waisman Biomanufacturing 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Waisman Biomanufacturing 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.12 Regeneus Ltd.
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Regeneus Ltd. 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Regeneus Ltd. 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.13 Organogenesis Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Organogenesis Inc. 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Organogenesis Inc. 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.14 Ocata Therapeutics Inc.
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Ocata Therapeutics Inc. 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Ocata Therapeutics Inc. 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.15 Medipost Co. Ltd.
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Medipost Co. Ltd. 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Medipost Co. Ltd. 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.16 Bone Therapeutics SA
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Bone Therapeutics SA 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Bone Therapeutics SA 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.17 BrainStorm Cell Therapeutics Inc.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 BrainStorm Cell Therapeutics Inc. 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 BrainStorm Cell Therapeutics Inc. 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
8.18 CellTherapies P/L
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 CellTherapies P/L 2015 Induced Pluripotent Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 CellTherapies P/L 2015 Induced Pluripotent Stem Cells Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.2.2 Europe 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.2.3 Japan 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.2.4 China 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.2.6 India 2016-2021 Induced Pluripotent Stem Cells Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Induced Pluripotent Stem Cells Marketing Model Analysis
10.1 Induced Pluripotent Stem Cells Regional Marketing Model Analysis
10.2 Induced Pluripotent Stem Cells International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Induced Pluripotent Stem Cells by Regions
10.4 Induced Pluripotent Stem Cells Supply Chain Analysis
11 Consumers Analysis of Induced Pluripotent Stem Cells
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Induced Pluripotent Stem Cells
12.1 New Project SWOT Analysis of Induced Pluripotent Stem Cells
12.2 New Project Investment Feasibility Analysis of Induced Pluripotent Stem Cells
13 Conclusion of the Global Induced Pluripotent Stem Cells Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
